C. Webster

发表

Synthesis of Diagnostic Silicon Nanoparticles for Targeted Delivery of Thiourea to Epidermal Growth Factor Receptor-Expressing Cancer Cells.

S. Krishnamurthy, Y. Chao, W. Al-Jamal, 2016, ACS applied materials & interfaces.

Combining Cytotoxicity Assessment and Xenopus laevis Phenotypic Abnormality Assay as a Predictor of Nanomaterial Safety

G. Wheeler, F. B. Bombelli, V. Sherwood, 2017, Current protocols in toxicology.

Synthesis of Carbohydrate Capped Silicon Nanoparticles and their Reduced Cytotoxicity, In Vivo Toxicity, and Cellular Uptake

U. Ruktanonchai, Y. Chao, N. Saengkrit, 2015, Advanced healthcare materials.

The scope of nanoparticle therapies for future metastatic melanoma treatment.

F. B. Bombelli, M. Moncrieff, V. Sherwood, 2014, The Lancet. Oncology.

An early developmental vertebrate model to assess nanomaterial safety: Bridging cell- based and mammalian nanoparticle toxicity assessment

Edoardo, G. Wheeler, M. Salmona, 2017 .

Hazard Assessment of Engineered Nanocarriers using in vitro and in vivo Studies

G. Wheeler, F. B. Bombelli, V. Sherwood, 2013 .

Acidification-Induced Structure Evolution of Lipid Nanoparticles Correlates with Their In Vitro Gene Transfections

C. F. van der Walle, S. Rogers, Zongyi Li, 2023, ACS nano.

An early developmental vertebrate model for nanomaterial safety: bridging cell-based and mammalian toxicity assessment.

G. Wheeler, M. Salmona, F. B. Bombelli, 2016, Nanomedicine.

Novel diagnostic silicon nanoparticles for targeted delivery of thiourea to EGFR-expressing cancer cells

Y. Chao, W. Al-Jamal, Mehrnaz Behray, 2018 .